NASDAQ

Pasithea Therapeutics Corp. (KTTA)

♥ 284 Thanks from members

Live price chart, market sentiment, and community perspectives for Pasithea Therapeutics Corp. (NASDAQ: KTTA).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: Biotechnology and PharmaceuticalsFounder: Dr. Pamela PalmerFounder: Mark AttallahLeadership: Mark Attallah (CEO)Leadership: Dr. Pamela Palmer (Chief Medical Officer)Holder: Pasithea Therapeutics ManagementHolder: Institutional InvestorsNeuropsychiatric TherapeuticsNovel Synaptic Plasticity Enhancers#KTTA#Pasithea Therapeutics#biotech stock#NASDAQ KTTA#CNS drug development